MANAGEMENT SHARE PURCHASES AND NEW PRESIDENT FOR THE US SUBSIDIARY

Three senior SCN executives have increased their shareholding in the company, and the former US Director of Sales and Marketing, Gwen Kent, has become new President of the US subsidiary SCN USA LLC.

Three senior SCN executives have recently increased their shareholding in the company with 280,000 shares in total. The principal owner and board member Carl-Gustaf Ingelman has purchased 130,000 shares, CEO Ulf Söderberg has purchased 100,000 shares and Business Strategy Manager Anders Struksnes has purchased 50,000 shares.

A change has also taken place within the company’s senior management, as Gwen Kent has assumed the position as new President for the US subsidiary SCN USA LLC. Gwen Kent was formerly Vice President and Director of Sales and Marketing for SCN USA LLC, and has extensive experience from the American dietary supplement business. Before joining SCN, Gwen Kent has worked for companies like Natural Inc., the US division of the Norwegian company Natural ASA (quoted on the Oslo Stock Exchange), and the American company Nutrition 21 (quoted on Nasdaq).

More information:

Ulf Söderberg, CEO, ulf.soderberg@scnutrition.se, +46 708 13 22 81

Scandinavian Clinical Nutrition AB (publ) works in R&D and sales of scientifically documented products within the field of nutrition (nutraceuticals). Established in 2006, SCN maintains a product portfolio with established trademarks, such as CUUR, Membraseven and Ledactin. Core competence and strategic alliances, within both R&D and sales, in combination with innovative and scientifically documented products, create the right conditions for profitable growth both in Sweden and on the company’s export markets. The SCN share is listed for trade on NGM Nordic MTF since December 6, 2006.